The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Computational Medicine and Drug Discovery Software Market Research Report 2024
Synopsis
Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
The global Computational Medicine and Drug Discovery Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Discovery Software.
Report Scope
The Computational Medicine and Drug Discovery Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Medicine and Drug Discovery Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Discovery Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Genedata
Crown Bioscience
Biognos
Chemical Computing Group
Leadscope
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger
Compugen
Dassault Systemes
Segment by Type
Database
Software
Others
Segment by Application
Computational Physiological Medicine
Drug Discovery And Development
Medical Imaging
Disease Modeling
Predictive Analysis Of Drug Targets
Cellular Simulation
Simulation Software
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Discovery Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
The global Computational Medicine and Drug Discovery Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Discovery Software.
Report Scope
The Computational Medicine and Drug Discovery Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Medicine and Drug Discovery Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Discovery Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Genedata
Crown Bioscience
Biognos
Chemical Computing Group
Leadscope
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger
Compugen
Dassault Systemes
Segment by Type
Database
Software
Others
Segment by Application
Computational Physiological Medicine
Drug Discovery And Development
Medical Imaging
Disease Modeling
Predictive Analysis Of Drug Targets
Cellular Simulation
Simulation Software
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Discovery Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Discovery Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Computational Physiological Medicine
1.3.3 Drug Discovery And Development
1.3.4 Medical Imaging
1.3.5 Disease Modeling
1.3.6 Predictive Analysis Of Drug Targets
1.3.7 Cellular Simulation
1.3.8 Simulation Software
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Discovery Software Market Perspective (2019-2030)
2.2 Computational Medicine and Drug Discovery Software Growth Trends by Region
2.2.1 Global Computational Medicine and Drug Discovery Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computational Medicine and Drug Discovery Software Historic Market Size by Region (2019-2024)
2.2.3 Computational Medicine and Drug Discovery Software Forecasted Market Size by Region (2025-2030)
2.3 Computational Medicine and Drug Discovery Software Market Dynamics
2.3.1 Computational Medicine and Drug Discovery Software Industry Trends
2.3.2 Computational Medicine and Drug Discovery Software Market Drivers
2.3.3 Computational Medicine and Drug Discovery Software Market Challenges
2.3.4 Computational Medicine and Drug Discovery Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue (2019-2024)
3.1.2 Global Computational Medicine and Drug Discovery Software Revenue Market Share by Players (2019-2024)
3.2 Global Computational Medicine and Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Medicine and Drug Discovery Software Revenue
3.4 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Discovery Software Revenue in 2023
3.5 Computational Medicine and Drug Discovery Software Key Players Head office and Area Served
3.6 Key Players Computational Medicine and Drug Discovery Software Product Solution and Service
3.7 Date of Enter into Computational Medicine and Drug Discovery Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Discovery Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Type (2019-2024)
4.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Type (2025-2030)
5 Computational Medicine and Drug Discovery Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Application (2019-2024)
5.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computational Medicine and Drug Discovery Software Market Size (2019-2030)
6.2 North America Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computational Medicine and Drug Discovery Software Market Size by Country (2019-2024)
6.4 North America Computational Medicine and Drug Discovery Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Discovery Software Market Size (2019-2030)
7.2 Europe Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2019-2024)
7.4 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size (2019-2030)
8.2 Asia-Pacific Computational Medicine and Drug Discovery Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Discovery Software Market Size (2019-2030)
9.2 Latin America Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2019-2024)
9.4 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size (2019-2030)
10.2 Middle East & Africa Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Detail
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Discovery Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.1.5 Entelos Recent Development
11.2 Genedata
11.2.1 Genedata Company Detail
11.2.2 Genedata Business Overview
11.2.3 Genedata Computational Medicine and Drug Discovery Software Introduction
11.2.4 Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.2.5 Genedata Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Detail
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Computational Medicine and Drug Discovery Software Introduction
11.3.4 Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.3.5 Crown Bioscience Recent Development
11.4 Biognos
11.4.1 Biognos Company Detail
11.4.2 Biognos Business Overview
11.4.3 Biognos Computational Medicine and Drug Discovery Software Introduction
11.4.4 Biognos Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.4.5 Biognos Recent Development
11.5 Chemical Computing Group
11.5.1 Chemical Computing Group Company Detail
11.5.2 Chemical Computing Group Business Overview
11.5.3 Chemical Computing Group Computational Medicine and Drug Discovery Software Introduction
11.5.4 Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.5.5 Chemical Computing Group Recent Development
11.6 Leadscope
11.6.1 Leadscope Company Detail
11.6.2 Leadscope Business Overview
11.6.3 Leadscope Computational Medicine and Drug Discovery Software Introduction
11.6.4 Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.6.5 Leadscope Recent Development
11.7 Nimbus Therapeutics
11.7.1 Nimbus Therapeutics Company Detail
11.7.2 Nimbus Therapeutics Business Overview
11.7.3 Nimbus Therapeutics Computational Medicine and Drug Discovery Software Introduction
11.7.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.7.5 Nimbus Therapeutics Recent Development
11.8 Rhenovia Pharma Limited
11.8.1 Rhenovia Pharma Limited Company Detail
11.8.2 Rhenovia Pharma Limited Business Overview
11.8.3 Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Introduction
11.8.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.8.5 Rhenovia Pharma Limited Recent Development
11.9 Schrodinger
11.9.1 Schrodinger Company Detail
11.9.2 Schrodinger Business Overview
11.9.3 Schrodinger Computational Medicine and Drug Discovery Software Introduction
11.9.4 Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.9.5 Schrodinger Recent Development
11.10 Compugen
11.10.1 Compugen Company Detail
11.10.2 Compugen Business Overview
11.10.3 Compugen Computational Medicine and Drug Discovery Software Introduction
11.10.4 Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.10.5 Compugen Recent Development
11.11 Dassault Systemes
11.11.1 Dassault Systemes Company Detail
11.11.2 Dassault Systemes Business Overview
11.11.3 Dassault Systemes Computational Medicine and Drug Discovery Software Introduction
11.11.4 Dassault Systemes Revenue in Computational Medicine and Drug Discovery Software Business (2019-2024)
11.11.5 Dassault Systemes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
